News

Recothrom is indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical

The license will permit Advanced BioScience Laboratories (ABL), based in Kensington, Maryland, to conduct certain internal research on DNA vaccines delivered using electroporation and to offer electroporation delivery

A Phase I/II safety and immunogenicity study in 15 HIV-infected patients (CD4 counts > 350 ul/ml) has begun enrolment in the US. The first safety data are expected

Cato Research Neuland India, the new joint venture company formed by Cato Research, Cato Research Israel and Neuland will assist health care companies in efficiently bringing innovative drugs

The comprehensive dossier detailing the grounds for re-examination addresses the three issues that formed the basis of the negative opinion issued by the CHMP on March 19, 2008.

This collaboration provides Takeda with broad, worldwide, non-exclusive access to and enablement with Alnylam’s RNAi therapeutics platform technology and intellectual property in the fields of oncology and metabolic

Elaprase, developed by Shire Human Genetic Therapies (HGT), a business unit of Shire focused on genetic diseases, is said to be the first and only enzyme replacement therapy

Under the agreement, Schering-Plough is responsible for the development, manufacturing and commercialization of Zegerid branded over-the-counter (OTC) products with the dosage strength of 20mg of omeprazole for heartburn-related

The facility was acquired from an affiliate of Oregon-based Westcare Management. The deal was struck in mid-2007, but closing was delayed while title issues on the real estate